Leif Angelison (Former)

1 – 5 of 5

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/dd57a87f-f5f8-47d4-8bb4-b6ddbdd96563?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2020
Mark Short and long-term efficacy of adalimumab in ulcerative colitis : a real-life study
Angelison, Leif ^LU ; Almer, Sven ; Davidsdottir, Loa ; Hammarlund, Per ; Lindgren, Stefan ^LU ; Hindorf, Ulf ^LU ; Marsal, Jan ^LU and Hertervig, Erik ^LU (2020) In Scandinavian Journal of Gastroenterology 55(2). p.154-162
- Contribution to journal › Article
2018
Mark Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease
Bergqvist, Viktoria ^LU ; Kadivar, Mohammad ^LU ; Molin, Daniel ^LU ; Angelison, Leif ^LU ; Hammarlund, Per ; Olin, Marie ^LU ; Torp, Jörgen ; Grip, Olof ^LU ; Nilson, Stefan and Hertervig, Erik ^LU , et al. (2018) In Therapeutic Advances in Gastroenterology 11.
- Contribution to journal › Article
Mark Clinical effectiveness of golimumab in Crohn’s disease : an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
Rundquist, Sara ; Eriksson, Carl ; Nilsson, Linda ; Angelison, Leif ^LU ; Jäghult, Susanna ; Björk, Jan ; Grip, Olof ^LU ; Hjortswang, Henrik ; Strid, Hans and Karlén, Per , et al. (2018) In Scandinavian Journal of Gastroenterology 53(44845). p.1257-1263
- Contribution to journal › Article
2017
Mark Long-term outcome of infliximab treatment in chronic active ulcerative colitis : a Swedish multicentre study of 250 patients
Angelison, Leif ^LU ; Almer, S. ; Eriksson, A. ; Karling, P. ; Fagerberg, U. ; Halfvarson, J. ; Thörn, M. ; Björk, J. ; Hindorf, U. ^LU and Löfberg, R. , et al. (2017) In Alimentary Pharmacology and Therapeutics 45(4). p.519-532
- Contribution to journal › Article
Mark Letter: how to define remission in ulcerative colitis – histological remission should be considered. Authors' reply
Angelison, L. ^LU ; Marsal, J. ^LU and Hertervig, E. ^LU (2017) In Alimentary Pharmacology and Therapeutics 45(8). p.1177-1178
- Contribution to journal › Letter